Alpna Seth

Insider Reports History

Entity
Individual
Location
614 Mckinley Place Ne, Minneapolis, MN
Signature
/s/ Andrew Nick as Attorney-in-Fact for Alpna Seth pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alpna Seth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp Director Common Stock 13.8K $1.01M $73.20 Oct 24, 2024 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10K May 30, 2024 Direct
BIO-TECHNE Corp Director Stock Options (Right to Buy) 3.94K Oct 26, 2023 Direct
BIO-TECHNE Corp Director Stock Options (Right to Buy) 3.51K Oct 24, 2024 Direct
Seagen Inc. Director Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 Dec 14, 2023 Direct

Insider Reports Filed by Alpna Seth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECH BIO-TECHNE Corp Oct 24, 2024 2 $0 4 Oct 28, 2024 Director
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 7 -$2.97M 4 Dec 15, 2023 Director
TECH BIO-TECHNE Corp Oct 26, 2023 2 $0 4 Oct 30, 2023 Director
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
KROS Keros Therapeutics, Inc. May 1, 2023 1 $0 4 May 3, 2023 Director
KROS Keros Therapeutics, Inc. May 1, 2023 0 $0 3 May 3, 2023 Director
TECH BIO-TECHNE Corp Oct 27, 2022 2 $0 4 Oct 31, 2022 Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
TECH BIO-TECHNE Corp Oct 28, 2021 2 $0 4 Nov 1, 2021 Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director